2:00   Genmab's 2030 Vision 1:45   Inside Genmab R&D: What Motivates Drug Research and Development? 1:59   DuoBody® Technology Platform 9:43   GMAB: Is Genmab the Most Undervalued Biotech on Nasdaq? 2:47   Inside Genmab R&D: Where Innovation Takes Shape 1:18   Welcome to Antibody Hour: Unveiling the Stories Driving Antibody Innovation 3:21   Genmab Corporate Video 0:31   For Genmab, transformational medicines for cancer patients start in New Jersey 1:53   Genmab's Antibody Drug Conjugate (ADC) Technology Platform 1:27   Shaping Innovations in Antibody Science 2:26   Antibody Science to Impact 2:36   Why Middlesex County, NJ? An Interview with GenMab 1:00   Genmab's Patient-Centric Focus 2:22   Genmab Stock Recovery Not To Be Mistaken For New Uptrend 1:32   HexaBody® Technology Platform 0:58   Innovation driven by Patient Insights 0:22   Genmab and AbbVie Partnership